Medicines & drugs recalls
909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.
Page 18 of 19
- BD ChloraPrep™ Clear: Affected lot may contain the presence of Aspergillus penicilloidesHealth CanadaProduct quality
- CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde is out of specification in the affected lots.Health CanadaProduct quality
- CanWe Growers Inc. recalls one lot of 7ASHISH - Lebanese Blonde cannabis extractHealth CanadaLabelling and packaging
- ENDO USA, Inc. recalls Adrenalin Chloride Solution (Epinephrine Nasal SolutionFDALabeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)
- Teva Pharmaceuticals USA, Inc recalls Granix (tbo-filgrastim) Injection 300 mcg/0.5 mLFDAFailed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Guaifenesin and Codeine Phosphate Oral Solution USPFDASuperpotent; sodium benzoate preservative
- SKY PACKAGING recalls HydrALAZINE HydrochlorideFDAFailed Impurities/Degradation Specifications
- Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsFDACGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
- RemedyRepack Inc. recalls Carvedilol 25 mg TabletFDACGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
- FDC Limited recalls Timolol Maleate Ophthalmic Solution USPFDADefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Potassium Chloride Extended-Release TabletsFDAFailed Dissolution Specifications.
- BIOV Health Calcium (Carbonate) recall due to deficiencies in Good Manufacturing Practices (GMP)Health CanadaProduct quality
- SENNA Tablet USP ; JAMP Senna ; Jamp - SENNA: total counts of yeasts and molds are out of specificationHealth CanadaProduct safety
- Astellas Pharma US Inc. recalls Prograf (tacrolimus) capsules and 1 moreFDAFailed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Duloxetine Delayed-Release Capsules USPFDACGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake…
- The W.S. Badger Company, Inc. recalls BADGER 50FDALabeling: Missing Label: The finished product potentially missing the labeling with the drug facts panel, bar code and directions for use.
- McKesson recalls Inflectra (infliximab-dyyb)FDACGMP Deviations: Product intended for quarantine was inadvertently distributed.
- Ferinject: labelled with the incorrect vial size on the outer carton.Health CanadaLabelling
- Lacosamide 10mg/ml : Presence of particulate matter in affected lot.Health CanadaProduct quality
- APO-QUETIAPINE XR - May exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP).Health CanadaProduct quality
- PMS-FLUOXETINE 10 mg - May contain capsules of PMS-Fluoxetine 20mg.Health CanadaProduct quality
- Brands International Corporation recalls Kissable Diabetics Foot CreamFDACGMP Deviations: lack of adequate release testing.
- SHOPPERS- PLAZA recalls FOUZEE SugarLin HERBAL FORMULA capsulesFDAMarketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide
- First Aid Beauty Ltd recalls First Aid Beauty Ultra Repair CreamFDACGMP Deviations; product intended for quarantine was inadvertently distributed
- Appco Pharma LLC recalls Venlafaxine Extended-Release TabletsFDAFailed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
- Akron Pharma, Inc. recalls Acetaminophen and 4 moreFDALabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
- Alcon Research LLC recalls Systane Lubricant Eye DropsFDANon-Sterility
- Amerisource Health Services LLC recalls glipiZIDEFDAFailed Dissolution Specifications:
- Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8 mg and 1 moreFDAFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
- Amerisource Health Services LLC recalls Clobazam TabletsFDAPresence of Foreign Tablets/Capsules
- Semaglutide + Pyridoxine: produced with an unauthorized active pharmaceutical ingredientHealth CanadaProduct quality
- Endo USA, Inc. recalls Clonazepam Orally Disintegrating Tablets and 1 moreFDALabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct…
- Jubilant Draximage Inc., dba Jubilant Radiopharma recalls Kit for the Preparation of Technetium Tc 99m Sulfur Colloid InjectionFDAFailed Stability Specifications
- Buy-Herbal recalls Nhan Sam Tuyet Lien Truy Phong HoanFDAMarketed without an Approved NDA/ANDA: FDA analysis found the products to be tainted with undeclared Furosemide, Dexamethasone and Chlorpheniramine
- West-Ward Columbus Inc recalls Methadone Hydrochloride TabletsFDAFailed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.
- FDC Limited recalls Ciprofloxacin Ophthalmic Solution USPFDADefective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
- Amerisource Health Services LLC recalls Clobazam TabletsFDAPresence of Foreign Tablets/Capsules
- Eugia US LLC recalls medroxyPROGESTERone Acetate Injectable SuspensionFDACGMP Deviations
- Granules Pharmaceuticals Inc. recalls Colchicine Capsules 0.6 mgFDAFailed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
- Eugia US LLC recalls Progesterone Injection USPFDAPresence of Particulate Matter: A market complaint was received of a glass piece in the vial.
- Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP 30 mg and 2 moreFDACGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
- Granules Pharmaceuticals Inc. recalls Metformin Hydrochloride Extended-Release TabletsFDAPresence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.
- AG-Escitalopram: may contain blisters of the foreign product Tillomed Gabapentin 100mg capsuleHealth CanadaProduct quality
- Lupin Pharmaceuticals Inc. recalls Levothyroxine Sodium TabletsFDAFailed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term…
- AvKARE recalls Nitrofurantoin CapsulesFDAFailed Dissolution Specifications
- VIONA PHARMACEUTICALS INC recalls Dapsone Gel 7.5%FDACrystallization
- Hikma Injectables USA Inc recalls ketamine inj 50 mg per 1 mL and 1 moreFDALack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
- SOMERSET THERAPEUTICS LLC recalls Atropine Sulfate Ophthalmic SolutionFDAFailed Impurities/Degradation Specifications
- GNMart LLC recalls FORCE FOREVER 400mg TabletsFDAMarketed without an approved NDA/ANDA. FDA analysis found the product to be tainted with Diclofenac and Dexamethasone.
- AvKARE recalls Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing… and 1 moreFDALABELING: LABEL MIX-UP